rare disease data center
50% Faster FDA Approvals? Rare Disease Data Center Myth
Rare disease data centers do not magically cut FDA review time in half; the perceived 50% speedup stems from a single ARC grant that accelerated one therapy by three months. That isolated case sparked headlines, but broader data show modest gains across many projects. I have followed the ARC program